We are currently experiencing technical issues due to the Microsoft outage. This will affect delivery of multi-factor authentication emails, invoice emails and service emails. We apologise for the disruption.

Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesTerrAscend Corp.

TerrAscend Corp.

Healthcare Drug Manufacturers - Specialty & Generic
PortfolioPortfolio WatchlistWatchlist
Company price
0.425 USD -0.02 ( 5.53%)
Last update at 2026-11-12T15:27:00Z
VOLUME
53515
Market Cap
0.00M

Momentum Score

…

TerrAscend Corp. cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. The company produces and distributes hemp-derived wellness products to retail locations; and manufactures cannabis-infused artisan edibles. It also operates retail dispensaries under the Apothecarium brand name in California, Pennsylvania, and New Jersey. In addition, the company owns various synergistic businesses under Gage Growth, Pinnacle, TerrAscend NJ, Ilera Healthcare, HMS Health and HMS Processing, Valhalla Confections, State Flower, Arise Bioscience Inc., and TerrAscend Canada brands. It serves medical and legal adult-use markets. The company was incorporated in 2017 and is headquartered in Mississauga, Canada.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.42
Low
0.44
High
52 Week Price Range
1.00
Low
2.34
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

TerrAscend Corp. is a vertically integrated cannabis company operating cultivation, manufacturing and retail businesses in licensed U.S. and Canadian markets. Major long-term growth drivers include expansion of legalized adult-use markets, scaling retail and wholesale distribution, and product development; its vertical integration and regulated-market presence may support market-share gains as demand grows.

Material risks include ongoing U.S. federal prohibition and regulatory uncertainty, intense sector competition, capital and liquidity pressures, and execution risk tied to scaling operations, and investors should monitor regulatory developments and balance-sheet metrics.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.45
Dividend Yield
-
Revenue TTM
0.00M
Revenue Per Share
-
Gross Profit TTM
0.00M
Debt / Equity
-
ROE
-
Net Debt
168.03M
ROCE
-3.72%
Diluted EPS TTM
-

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Income before tax -310.19M 34.45M -99.18M -166.37M
Minority interest 4.56M -3.02M -0.61M 2.42M
Net income -303.96M 3.11M -121.65M -165.19M
Selling general administrative 106.15M 80.97M 58.95M 47.22M
Gross profit 101.50M 112.10M 113.86M 6.38M
Reconciled depreciation 24.60M 16.64M 13.00M 5.60M
Ebit -20.97M 35.33M 20.68M -44.31M
Ebitda -246.52M 77.14M 59.82M -39.99M
Operating income -14.30M 23.48M 46.82M -45.59M
Other operating expenses - - - 0.72M
Interest expense 39.06M 26.06M 11.05M 4.34M
Tax provision 10.78M 28.31M 21.86M 1.24M
Net interest income -39.06M -26.06M -11.05M -4.34M
Income tax expense -10.78M 28.88M 10.77M 1.77M
Total revenue 247.83M 210.42M 155.52M 64.97M
Total operating expenses 262.13M 186.94M 108.70M 110.56M
Cost of revenue 146.32M 98.31M 41.66M 58.59M
Total other income expense net -256.82M 37.03M -134.95M -116.44M
Discontinued operations -25.95M -9.52M -14.63M -14.63M
Net income from continuing ops -320.97M 6.13M -121.04M -167.62M
Net income applicable to common shares -329.91M 3.11M -139.20M -160.67M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 701.59M 581.93M 473.57M 352.73M
Intangible assets 239.70M 168.98M 120.85M 111.29M
Other current assets 18.52M 39.23M 5.16M 5.48M
Total liab 380.42M 352.98M 464.85M 295.07M
Total stockholder equity 318.80M 223.59M 0.93M 51.05M
Other current liab 42.10M 28.75M 59.34M 41.30M
Capital stock 0.00M 535.42M 251.95M 198.96M
Retained earnings -618.26M -314.65M -318.59M -182.56M
Other liab 47.20M 84.88M 146.78M 145.54M
Good will 90.33M 90.33M 78.83M 73.32M
Other assets 4.30M 9.08M 13.34M 11.51M
Cash 26.16M 79.64M 59.14M 9.11M
Total current liabilities 137.91M 66.19M 93.48M 109.83M
Net debt 168.03M 105.50M 129.20M 54.61M
Short long term debt 48.34M 8.84M 5.72M 48.28M
Other stockholder equity 2.08M 2.82M -3.66M -0.79M
Property plant equipment 245.26M 141.61M 133.47M 87.78M
Total current assets 121.99M 172.49M 95.55M 64.82M
Long term investments - - 1.38M 0.99M
Net tangible assets -11.23M -35.16M -200.62M -131.72M
Short term investments 3.60M - - 0.36M
Net receivables 22.44M 12.49M 10.86M 34.94M
Long term debt 145.85M 176.31M 182.61M 15.44M
Inventory 46.34M 36.09M 20.56M 15.53M
Accounts payable 44.29M 27.92M 27.38M 19.40M
Non currrent assets other 3.46M 5.11M 3.92M -
Non current assets total 579.59M 438.71M 345.99M 283.27M
Capital lease obligations 40.64M 31.95M 24.28M 15.87M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Investments -27.58M -49.53M 0.15M 1.81M
Change to liabilities -11.68M 3.29M 7.43M 2.45M
Total cashflows from investing activities -27.58M -132.42M -45.89M -104.22M
Net borrowings 0.07M -3.73M 147.46M 58.18M
Total cash from financing activities 3.72M 182.20M 133.41M 136.93M
Change to operating activities -6.43M -10.68M -59.95M -1.50M
Net income -329.91M 3.11M -139.20M -160.67M
Change in cash -52.88M 20.42M 50.06M -6.80M
Begin period cash flow 79.64M 59.23M 9.33M 16.67M
End period cash flow 26.76M 79.64M 59.14M 9.11M
Total cash from operating activities -26.12M -31.82M -36.97M -39.84M
Issuance of capital stock 0.00M 173.48M 74.98M 51.01M
Depreciation 24.60M 13.86M 12.52M 5.53M
Other cashflows from investing activities -0.09M -0.62M -0.89M -4.34M
Change to inventory 0.68M -18.51M -8.09M -6.65M
Change to account receivables 2.86M -3.21M -4.04M 0.20M
Other cashflows from financing activities -20.70M -18.33M -92.36M 1.91M
Change to netincome 279.15M -12.74M 143.00M 118.15M
Capital expenditures 39.63M 39.84M 43.78M 32.83M
Change in working capital 0.03M -36.80M -11.57M -5.22M
Stock based compensation 12.16M 14.94M 13.00M 9.82M
Other non cash items 3.21M 15.73M 1.53M 49.61M
Free cash flow -68.02M -72.66M -22.03M -71.18M

Peer Comparison*

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
TSNDF
TerrAscend Corp.		 -0.02
5.53%		 0.42 - - - -
MKKGY
Merck KGaA ADR		 -0.74
2.19%		 33.06 21.25 14.93 3.10 2.14
MKGAF
MERCK Kommanditgesellschaft auf Aktien		 -
-%		 170.05 24.86 15.11 3.13 1.98
TAK
Takeda Pharmaceutical Co Ltd ADR		 0.34
1.66%		 21.18 - 10.96 0.01 1.20
TKPHF
Takeda Pharmaceutical Co. Ltd.		 -
-%		 41.72 - 10.66 0.01 1.16

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

CJT
CAD 111.15
+12.71%
CLS
CAD 374.20
+8.33%
GRZ
CAD 4.90
+7.46%
CTC-A
CAD 218.05
+6.38%
FEC
CAD 7.42
+5.85%
TF
CAD 4.13
-19.65%
TLO
CAD 5.98
-15.06%
FSZ
CAD 2.45
-14.04%
XNDU
CAD 3.60
-8.86%
ITR
CAD 2.75
-8.50%

Equity Sectors*

  • Basic Materials

    -2.63%

  • Communication Services

    -0.79%

  • Consumer Cyclical

    +0.08%

  • Consumer Defensive

    -0.12%

  • Energy

    +0.52%

  • Financial Services

    -1.15%

  • Healthcare

    -1.74%

  • Industrials

    -0.64%

  • Real Estate

    -0.12%

  • Technology

    -0.51%

  • Utilities

    -0.02%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…